Product logins

Find logins to all Clarivate products below.


Strategic Vaccines – Epidemiology – Vaccines Epidemiology Forecaster

The Vaccines Epidemiology Forecaster allows you to interactively assess assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a specified country in order to size the potential patient population a vaccine could reach.

QUESTIONS ANSWERED

  • What is the addressable market for vaccines in development, and how will that change over time?
  • What is the current coverage of a vaccine in a specific country?
  • What assumptions can I make for a new vaccine launch based on comparator products in a given country or region?

GEOGRAPHIES

  • Global, with additional granularity for the G7

EPIDEMIOLOGY

  • Patient population data by country or region and income status, with an algorithm to make extrapolations for missing data on vaccine coverage, based on similarities in GDP.

COVERAGE

  • Vaccine coverage includes: BCG, DTP, polio, hep B (birth dose), HPV, Japanese encephalitis, MCV, rota, yellow fever

DATA & FEATURES

  • Delivered as a stand-alone Excel model based on DRG’s gold-standard epidemiology for vaccine coverage.
  • G7 dashboard facilitates a more-granular analysis in the mature markets.
  • Options to incorporate additional primary or secondary data and customizable deliverables.
  • Access to DRG’s expert epidemiologists for bespoke support.

Related Market Assessment Reports

Report
Multiple System Atrophy – Epidemiology – Epidemiology – Multiple system atrophy – Mature Markets
Clarivate Epidemiology’s coverage of multiple system atrophy (MSA) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…
Report
Multiple System Atrophy – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of multiple system atrophy (MSA) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…
Report
Leber’s Hereditary Optic Neuropathy – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of Leber’s hereditary optic neuropathy (LHON) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the…
Report
Obesity – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key obesity / overweight patient populations, covering 171 countries…
Report
Obesity – Epidemiology – Asia Pacific
Clarivate Epidemiology’s coverage of obesity / overweight comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of obesity / overweight…